DOI 10.1016/j.ijpharm.2025.126162
Therapeutic potential of phosphodiesterase inhibitor-loaded nanomicelles to treat endotoxin-induced anterior uveitis.
Аннотация
Uveitis is an ocular inflammatory condition that can be infectious or non-infectious, affecting various ocular structures. Corticosteroids and immunomodulators are the current standard of care for treating anterior uveitis, which has side effects such as cataracts and increased intraocular pressure. Therefore, a continuous search is going on to find an alternate strategy (steroid-sparing agent) to treat uveitis with improved safety. Apremilast, a phosphodiesterase-4 (PDE-4) inhibitor, has an anti-inflammatory activity, which could regulate the production of inflammatory mediators such as TNF-alpha and nitric oxide by inhibiting the conversion of cyclic adenosine monophosphate to adenosine monophosphate. A dose-inverted therapeutic effect was observed for Apremilast to treat acute anterior uveitis in an endotoxin-induced uveitis rat model. Further, to address the poor solubility and permeability, Apremilast-loaded nanomicelles (Aprecel) were developed and thoroughly characterized. Ocular pharmacokinetics study indicates that the developed nanomicelles facilitated the permeation of Apremilast across the corneal barrier due to increased solubility and residence time. Also, an in vivo efficacy study shows that the developed Aprecel effectively reduces the cell infiltration and protein levels in the endotoxin-induced uveitis rat model, along with inflammatory cytokines such as TNF-alpha. Therefore, Apremilast-loaded nanomicelles could be used as a potential steroid-sparing alternative to treat acute anterior uveitis with reduced side effects.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.